NCT06542835 · University of Arizona
Community Partnership for Telehealth Solutions to Convey Information and Enhance Care
(PRIME)
What this study is about
Non-randomly assigned, two-treatment group$1 stepped-wedge trial of a multi-level colorectal cancer screening intervention.
View original scientific description
Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.
Interventions
BEHAVIORAL
Video text message
Video text messages tailored to the Latinx population to educate and motivate patients to complete CRC screening.
BEHAVIORAL
In-clinic CRC screening promotion
Stool-test orders, colonoscopy referrals.
BEHAVIORAL
Mailed FIT
Mailed FIT kits.
BEHAVIORAL
Social needs navigation
Patient navigation to address social needs.
BEHAVIORAL
Reminders
Centralized text and/or telephone reminders for ordered tests.
Primary outcome measures
CRC Screening Completion at the Individual Level
Time frame: 6 months
Measure the completion rate of colorectal cancer (CRC) screening at the individual level within 6 months of receiving the intervention. This will compare the proportion of participants in the post-intervention group versus the pre-intervention group.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Eligible for colorectal cancer (CRC) screening
- Current patients (seen in the clinic in the last 6 months)
- Primary speaker of English or Spanish
- Cell phone listed in Electronic Health Record (EHR)
- No recent history of CRC screening
- Resides in one of the neighborhoods included in the main trial
Exclusion criteria
- Colorectal disease (e.g., ulcerative colitis or colectomy)
- Personal history of colorectal cancer
- End-stage or life-threatening diseases
- Known to be under hospice care
- Living in a skilled nursing facility
- Patients who decline research participation will be removed from the patient contact list
Where
- Los Angeles, California
Collaborators
San Diego State University, AltaMed Health Services Corporation, Kaiser Permanente
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Mar 30, 2026 · Source of record for eligibility and locations